
United States · Medical devices startup
BridgePoint Medical, Inc.
Funding reportedLast round: Series C
BridgePoint Medical, Inc.
was a medical device company based in Minneapolis, Minnesota, founded in 2007. The company focused on developing catheter-based technologies specifically for treating coronary chronic total occlusions (CTOs) in interventional cardiology. BridgePoint specialized in proprietary systems designed to address CTOs, which affect a significant portion of angiography patients and can lead to invasive bypass surgery. The company's key products included the CrossBossTM CTO Catheter, which helps navigate diseased coronary arteries, and the StingrayTM CTO Re-Entry System, which restores blood flow after crossing. Together, these formed the BridgePoint Medical CTO System, the only FDA-cleared and CE Mark-approved system in the U.S. for coronary CTOs at the time. In September 2012, BridgePoint was acquired by Boston Scientific Corporation, integrating its technologies into a larger portfolio.
Funding, as reported
From the SEC filings it signed: 4 on the team.
On the board, as filediAndrew FirlikBrian CheeJohn NehraMichael Berman
What they build
Known for
health caremedical equipment manufacturinghospital & health carehealthmedical deviceshealthcarewellness & fitness
Add your raise, your deck and your story, and put BridgePoint Medical, Inc. in front of investors. Or tell us what we have wrong.